Skip to Main Content

Paper Details

Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial.
Leukemia
50
2021
Author NameAffiliation
Susan GeyerMayo Clinic
Dietger NiederwieserUniversity of Leipzig
Bruno C MedeirosStanford Comprehensive Cancer Center, Stanford University
Martin S TallmanMemorial Sloan Kettering Cancer Center
Richard M StoneDana-Farber Cancer Institute
  • 1 - 5

Datasets

Release 1.2